Skip to main content
. Author manuscript; available in PMC: 2019 Jan 2.
Published in final edited form as: Vaccine. 2017 Nov 23;36(1):170–178. doi: 10.1016/j.vaccine.2017.10.080

Table 5.

Comparison of supplementary immunization activity (SIA) weighted coverage reaching zero-dose children with coverage of routine measles first dose (MCV1)

Country DHS survey year Weighted proportion of zero-dose children reached with SIA (95% CI) MCV1 coverage during SIA* Increase in measles vaccine coverage after SIA (95% CI)**
Benin 2006 70% (68–72%) 61% 27% (26–29%)
Burkina Faso 2003 74% (64–83%) 63% 27% (18–37%)
Democratic Republic of the Congo 2007 89% (87–91%) 68% 28% (27–30%)
Ghana 2003 51% (49–54%) 78% 11% (9–14%)
Ghana 2008 53% (49–57%) 85% 8% (4–12%)
Guinea 2005 60% (57–63%) 47% 32% (29–35%)
Haiti 2005 47% (37–57%) 56% 21% (10–31%)
Honduras 2005 59% (56–61%) 92% 5% (2–7%)
Indonesia 2002 87% (86–88%) 72% 24% (23–26%)
Kenya 2003 66% (63–69%) 78% 15% (12–17%)
Lesotho 2004 56% (52–60%) 80% 11% (7–15%)
Niger 2006 79% (77–81%) 46% 43% (41–45%)
Nigeria 2008 90% (88–92%) 43% 51% (49–53%)
São Tomé and Príncipe 2008 20% (16–24%) 86% 3% (0–7%)
Sierra Leone 2008 83% (79–86%) 69% 26% (23–29%)
*

The year of MCV1 coverage listed is the year during which the SIA took place. Source: World Health Organization. (2015). WHO/UNICEF coverage estimates for 1980–2014. Geneva: WHO/UNICEF. Last updated: 4 November 2015.

**

Assumes that the weighted SIA coverage addresses the current gap in MCV1 coverage, i.e., (1 – MCV1 coverage)*(Weighted proportion of zero-dose children reached with SIA).

Note: “Zero-dose children” are defined as children with no previous history of measles vaccination.